Skip to main content
ASOHNS ASM 2025
ASOHNS ASM 2025
Times are shown in your local time zone GMT

A Review of Submandibular Gland Extirpation in an Australian Quaternary Referral Centre: Aetiologies and Trends over 35 years

Verbal Presentation
Edit Your Submission
Edit

Verbal Presentation

2:10 pm

29 March 2025

Meeting Room C2.4

CONCURRENT SESSION 3E: FREE PAPERS

Disciplines

Default

Presentation Description

Institution: Chris O'Brien Lifehouse - NSW, Australia

Background: Submandibular gland pathology is common but rarely reported. This study was performed to evaluate demographic, pathological, and survival outcomes associated with submandibular gland extirpation. Methods: Retrospective analysis of patients treated in a single quaternary-care institution between 1989 and 2022 was performed. Results: 460 patients underwent submandibular gland extirpation with a female preponderance (n = 271, 59%) and a mean age of 51 years. Older age was associated with increased risk of malignancy (p<0.001). Submandibular calculus was the most common pathology, with gland extirpation for this indication decreasing over time (p=0.005). Pleomorphic adenoma was the most common benign tumour (n=96, 52.7% of total tumours), and adenoid cystic carcinoma was the most common malignant tumour (n= 25, 13.7% of total tumours). Conclusions: Submandibular calculus remains the most common indication for submandibular gland extirpation, although the rate is decreasing over time. Pleomorphic adenoma continues to be the most common tumour of the submandibular gland, whilst adenoid cystic carcinoma is the most common malignant tumour. The incidence of benign versus malignant tumours has remained constant over the period of this study.

Speakers

Authors

Authors

Dr Aki Flame - , Professor Hubert Low - , Professor Jonathan Clark - , Professor Michael Elliott - , Professor Carsten Palme - , Professor Ruta Gupta - , Dr Kerwin Shannon - , Dr James Wykes - , Dr Timothy Manzie - , Dr Veronica Cheung -